Choksi Laborator

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE493D01013
  • NSEID:
  • BSEID: 526546
INR
101.80
2.3 (2.31%)
BSENSE

Apr 30

BSE+NSE Vol: 354

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 525405,
    "name": "Choksi Laborator",
    "stock_name": "Choksi Laborator",
    "full_name": "Choksi Laboratories Ltd",
    "name_url": "stocks-analysis/choksi-laborator",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "101.80",
    "chg": 2.3,
    "chgp": "2.31%",
    "dir": 1,
    "prev_price": "99.50",
    "mcapval": "72.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526546,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE493D01013",
    "curr_date": "Apr 30",
    "curr_time": "",
    "bse_nse_vol": "354 ",
    "exc_status": "Active",
    "traded_date": "Apr 30, 2026",
    "traded_date_str": "2026 04 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/choksi-laborator-525405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-3963000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3963000.png",
        "date": "2026-04-26 10:10:34",
        "description": "Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvement-and-valuation-appeal-3945143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3945143.png",
        "date": "2026-04-14 08:07:19",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook, even as its fundamental and financial metrics remain under pressure. The revised rating highlights a mild improvement in technical indicators, balanced against persistent challenges in valuation and financial trends."
      },
      {
        "title": "Choksi Laboratories Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3936456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3936456.png",
        "date": "2026-04-08 08:03:13",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating as of 7 April 2026. The downgrade reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, signalling caution for investors amid challenging market conditions."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-flat-financials-3929568",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3929568.png",
        "date": "2026-04-02 08:03:11",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing fundamental challenges, signalling a cautious but slightly more optimistic stance from analysts."
      },
      {
        "title": "Choksi Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3923432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3923432.png",
        "date": "2026-03-30 08:02:02",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 27 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and ongoing valuation concerns, signalling heightened risks for investors amid a challenging market environment."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement Despite Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvement-despite-fundamental-challenges-3906280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3906280.png",
        "date": "2026-03-23 08:01:13",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges, prompting a reassessment of its valuation and market positioning."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-strong-sell-3893139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3893139.png",
        "date": "2026-03-16 10:10:47",
        "description": "Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Choksi Laboratories Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/choksi-laboratories-ltd-falls-to-52-week-low-amidst-continued-downtrend-3869952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_priceRelatedfactors_3869952.png",
        "date": "2026-03-04 12:44:53",
        "description": "Choksi Laboratories Ltd, a player in the Healthcare Services sector, has touched a new 52-week low of Rs.81.85 today, marking a significant decline amid ongoing market pressures and sector underperformance. The stock’s recent performance highlights persistent challenges reflected in its valuation and financial metrics."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-strong-sell-3868816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ChoksiLaborator_mojoScore_3868816.png",
        "date": "2026-03-04 10:10:55",
        "description": "Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 293,
    "sid": "525405",
    "stock_news_url": "https://www.marketsmojo.com/news/choksi-laboratories-525405"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "28-Apr-2026",
      "details": "Submission of scrutinizer report along with voting result of e-voting done by shareholder by means of postal ballot",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "28-Apr-2026",
      "details": "Submission of Voting result along with Scrutinizer report of e-voting done by shareholders of the company by means of postal ballot",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "15-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Choksi Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85195MP1993PLC007471</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>28.40</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Prakhar Dubey <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: compliance_officer@choksilab.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vyangesh Choksi <br/> Designation: Chief Financial Officer <br/> EmailId: v.choksi@choksilab.com</div> </div> <div> <br/> Date: 15/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Scrutinizers Report

28-Apr-2026 | Source : BSE

Submission of scrutinizer report along with voting result of e-voting done by shareholder by means of postal ballot

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

28-Apr-2026 | Source : BSE

Submission of Voting result along with Scrutinizer report of e-voting done by shareholders of the company by means of postal ballot

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

15-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyChoksi Laboratories Ltd
2CIN NO.L85195MP1993PLC007471
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 28.40
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Prakhar Dubey
Designation: Company Secretary and Compliance Officer
EmailId: compliance_officer@choksilab.in
Name of the Chief Financial Officer: Vyangesh Choksi
Designation: Chief Financial Officer
EmailId: v.choksi@choksilab.com

Date: 15/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available